我國結直腸癌的現狀、制約瓶頸與反思_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

于永揚 , 陳海寧 ,  周總光

四川大學華西醫院胃腸外科（成都 610041）;

Corresponding?author：

周總光, Email: zhou767@163.com

Keywords：

DOI：

10.7507/1007-9424.201907061

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 于永揚, 陳海寧, 周總光. 我國結直腸癌的現狀、制約瓶頸與反思. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2019, 26(8): 897-902. doi: 10.7507/1007-9424.201907061 Copy

1.	Vuik FE, Nieuwenburg SA, Bardou M, et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut, 2019, [Epub ahead of print].
2.	Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol, 2018, 4(11): 1553-1568.
3.	Connell LC, Mota JM, Braghiroli MI, et al. The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment. Curr Treat Options Oncol, 2017, 18(4): 23.
4.	Peterse EFP, Meester RGS, Siegel RL, et al. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: microsimulation analysis Ⅰ to inform the American Cancer Society colorectal cancer screening guideline. Cancer, 2018, 124(14): 2964-2973.
5.	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
6.	鄭榮壽, 孫可欣, 張思維, 等. 2015年中國惡性腫瘤流行情況分析. 中華腫瘤雜志, 2019, 41(1): 19-28.
7.	Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol, 2017, 3(4): 524-548.
8.	Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 2010, 19(8): 1893-1907.
9.	Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut, 2017, 66(4): 683-691.
10.	Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin, 2018, 68(4): 250-281.
11.	GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 2016, 388(10053): 1659-1724.
12.	Doubeni CA, Corley DA, Quinn VP, et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut, 2018, 67(2): 291-298.
13.	Troeung L, Sodhi-Berry N, Martini A, et al. Increasing incidence of colorectal cancer in adolescents and young adults aged 15-39 years in Western Australia 1982-2007: examination of colonoscopy history. Front Public Health, 2017, 5: 179.
14.	Rosato V, Bosetti C, Levi F, et al. Risk factors for young-onset colorectal cancer. Cancer Causes Control, 2013, 24(2): 335-341.
15.	Patel P, De P. Trends in colorectal cancer incidence and related lifestyle risk factors in 15-49-year-olds in Canada, 1969-2010. Cancer Epidemiol, 2016, 42: 90-100.
16.	王蘋, 王晶, 李剛, 等. 2015年北京市居民惡性腫瘤死亡分析. 首都公共衛生, 2017, 11(1): 17-19.
17.	鮑萍萍, 吳春曉, 張敏璐, 等. 2015年上海市惡性腫瘤流行特征分析. 中國癌癥雜志, 2019, 29(2): 81-99.
18.	劉華章, 林國楨. 2017–2018廣州市腫瘤登記年報. 廣州: 羊城晚報出版社, 2018: 23-27.
19.	Kelly D, Yang L, Pei Z. Gut microbiota, fusobacteria, and colorectal cancer. Diseases, 2018, 6(4): E109.
20.	Yan X, Liu L, Li H, et al. Clinical significance of Fusobacterium nucleatum, epithelial-mesenchymal transition, and cancer stem cell markers in stage Ⅲ/Ⅳ colorectal cancer patients. Onco Targets Ther, 2017, 10: 5031-5046.
21.	Mima K, Nishihara R, Qian ZR, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut, 2016, 65(12): 1973-1980.
22.	Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatumpromotes chemoresistance to colorectal cancer by modulating autophagy. Cell, 2017, 170(3): 548-563.
23.	Mehta RS, Nishihara R, Cao Y, et al. Association of dietary patterns with risk of colorectal cancer subtypes classified byfusobacterium nucleatum in tumor tissue. JAMA Oncol, 2017, 3(7): 921-927.
24.	Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer. 2019-07-07. https://gco.iarc.fr/today.
25.	Wolin KY, Yan Y, Colditz GA, et al. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer, 2009, 100(4): 611-616.
26.	CDC’s National Program of Cancer Registries Measuring Progress. National Program of Cancer Registries. Measuring Progress. Targeting action. https://www.cdc.gov/cancer/npcr/pdf/NPCR-FactSheet-508.pdf.
27.	Henson KE, Elliss-Brookes L, Coupland VH, et al. Data resource profile: National Cancer Registration Dataset in England. Int J Epidemiol, 2019, [Epub ahead of print].
28.	Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat, 2018, 50(2): 303-316.
29.	Cancer Information Service. Cancer statistics in Japan’18. 2019-07-01. https://ganjoho.jp/en/professional/statistics/brochure/2018_en.html.
30.	Bray F, Znaor A, Cueva P, et al. Planning and developing population-based cancer registration in low- and middle-income settings. IARC, 2014: 1-8.
31.	Shi JF, Huang HY, Guo LW, et al. Quality-of-life and health utility scores for common cancers in China: a multicentre cross-sectional survey. The Lancet, 2016, 388(Suppl 1): S29.
32.	石菊芳, 石春雷, 岳馨培, 等. 1996-2014年中國惡性腫瘤經濟負擔的系統評價. 中華腫瘤雜志, 2016, 38(12): 929-941.
33.	Xu T, Wu J. Financial toxicity of cancer in China. J Cancer Policy, 2018, 15: 96-99.
34.	Lin JS, Piper MA, Perdue LA, et al. Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force. JAMA, 2016, 315(23): 2576-2594.
35.	Seventieth World Health Assembly. Cancer prevention and control in the context of an integrated approach. 2018-05-15. http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_R12-en.pdf.
36.	United Nations. 2011 high level meeting on prevention and control of non-communicable diseases. 2018-05-15. http://www.un.org/en/ga/ncdmeeting2011/.
37.	World Health Organization. Global action plan for the prevention and control of NCDs 2013-2020. 2018-05-15. http://www.who.int/nmh/events/ncd_action_plan/en/.
38.	GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 2017, 390(10100): 1345-1422.
39.	周總光, 楊烈, 李園, 等. 我國結直腸癌30年變遷與應對策略. 中國實用外科雜志, 2012, 32(9): 693-696.
40.	Ou J, Peng Y, Yang W, et al. ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield. Nat Commun, 2019, 10(1): 1078.
41.	Liu X, Wang B, Li Y, et al. Powerful anticolon tumor effect of targeted gene immunotherapy using folate-modified nanoparticle delivery of CCL19 to activate the immune system. ACS Cent Sci, 2019, 5(2): 277-289.
42.	He Q, Guo S, Qian Z, et al. Development of individualized anti-metastasis strategies by engineering nanomedicines. Chem Soc Rev, 2015, 44(17): 6258-6286.
43.	Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst, 2017, 109(8): djw322.
44.	Deng Y. Rectal cancer in Asian vs. Western countries: why the variation in incidence? Curr Treat Options Oncol, 2017, 18(10): 64.
45.	Global Burden of Disease Cancer Collaboration. The global burden of cancer 2013. JAMA Oncol, 2015, 1(4): 505-527.
46.	Karahalios A, English DR, Simpson JA. Weight change and risk of colorectal cancer: a systematic review and meta-analysis. Am J Epidemiol, 2015, 181(11): 832-845.
47.	GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015, 385(9963): 117-171.
48.	International Agency for Research on Cancer, World Health Organization. CI5plus-cancer incidence in five continents time trends. 2018-04-01. http://ci5.iarc.fr/CI5plus/Default.aspx.

1. Vuik FE, Nieuwenburg SA, Bardou M, et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut, 2019, [Epub ahead of print].
2. Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol, 2018, 4(11): 1553-1568.
3. Connell LC, Mota JM, Braghiroli MI, et al. The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment. Curr Treat Options Oncol, 2017, 18(4): 23.
4. Peterse EFP, Meester RGS, Siegel RL, et al. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: microsimulation analysis Ⅰ to inform the American Cancer Society colorectal cancer screening guideline. Cancer, 2018, 124(14): 2964-2973.
5. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
6. 鄭榮壽, 孫可欣, 張思維, 等. 2015年中國惡性腫瘤流行情況分析. 中華腫瘤雜志, 2019, 41(1): 19-28.
7. Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol, 2017, 3(4): 524-548.
8. Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 2010, 19(8): 1893-1907.
9. Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut, 2017, 66(4): 683-691.
10. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin, 2018, 68(4): 250-281.
11. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 2016, 388(10053): 1659-1724.
12. Doubeni CA, Corley DA, Quinn VP, et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut, 2018, 67(2): 291-298.
13. Troeung L, Sodhi-Berry N, Martini A, et al. Increasing incidence of colorectal cancer in adolescents and young adults aged 15-39 years in Western Australia 1982-2007: examination of colonoscopy history. Front Public Health, 2017, 5: 179.
14. Rosato V, Bosetti C, Levi F, et al. Risk factors for young-onset colorectal cancer. Cancer Causes Control, 2013, 24(2): 335-341.
15. Patel P, De P. Trends in colorectal cancer incidence and related lifestyle risk factors in 15-49-year-olds in Canada, 1969-2010. Cancer Epidemiol, 2016, 42: 90-100.
16. 王蘋, 王晶, 李剛, 等. 2015年北京市居民惡性腫瘤死亡分析. 首都公共衛生, 2017, 11(1): 17-19.
17. 鮑萍萍, 吳春曉, 張敏璐, 等. 2015年上海市惡性腫瘤流行特征分析. 中國癌癥雜志, 2019, 29(2): 81-99.
18. 劉華章, 林國楨. 2017–2018廣州市腫瘤登記年報. 廣州: 羊城晚報出版社, 2018: 23-27.
19. Kelly D, Yang L, Pei Z. Gut microbiota, fusobacteria, and colorectal cancer. Diseases, 2018, 6(4): E109.
20. Yan X, Liu L, Li H, et al. Clinical significance of Fusobacterium nucleatum, epithelial-mesenchymal transition, and cancer stem cell markers in stage Ⅲ/Ⅳ colorectal cancer patients. Onco Targets Ther, 2017, 10: 5031-5046.
21. Mima K, Nishihara R, Qian ZR, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut, 2016, 65(12): 1973-1980.
22. Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatumpromotes chemoresistance to colorectal cancer by modulating autophagy. Cell, 2017, 170(3): 548-563.
23. Mehta RS, Nishihara R, Cao Y, et al. Association of dietary patterns with risk of colorectal cancer subtypes classified byfusobacterium nucleatum in tumor tissue. JAMA Oncol, 2017, 3(7): 921-927.
24. Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer. 2019-07-07. https://gco.iarc.fr/today.
25. Wolin KY, Yan Y, Colditz GA, et al. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer, 2009, 100(4): 611-616.
26. CDC’s National Program of Cancer Registries Measuring Progress. National Program of Cancer Registries. Measuring Progress. Targeting action. https://www.cdc.gov/cancer/npcr/pdf/NPCR-FactSheet-508.pdf.
27. Henson KE, Elliss-Brookes L, Coupland VH, et al. Data resource profile: National Cancer Registration Dataset in England. Int J Epidemiol, 2019, [Epub ahead of print].
28. Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat, 2018, 50(2): 303-316.
29. Cancer Information Service. Cancer statistics in Japan’18. 2019-07-01. https://ganjoho.jp/en/professional/statistics/brochure/2018_en.html.
30. Bray F, Znaor A, Cueva P, et al. Planning and developing population-based cancer registration in low- and middle-income settings. IARC, 2014: 1-8.
31. Shi JF, Huang HY, Guo LW, et al. Quality-of-life and health utility scores for common cancers in China: a multicentre cross-sectional survey. The Lancet, 2016, 388(Suppl 1): S29.
32. 石菊芳, 石春雷, 岳馨培, 等. 1996-2014年中國惡性腫瘤經濟負擔的系統評價. 中華腫瘤雜志, 2016, 38(12): 929-941.
33. Xu T, Wu J. Financial toxicity of cancer in China. J Cancer Policy, 2018, 15: 96-99.
34. Lin JS, Piper MA, Perdue LA, et al. Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force. JAMA, 2016, 315(23): 2576-2594.
35. Seventieth World Health Assembly. Cancer prevention and control in the context of an integrated approach. 2018-05-15. http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_R12-en.pdf.
36. United Nations. 2011 high level meeting on prevention and control of non-communicable diseases. 2018-05-15. http://www.un.org/en/ga/ncdmeeting2011/.
37. World Health Organization. Global action plan for the prevention and control of NCDs 2013-2020. 2018-05-15. http://www.who.int/nmh/events/ncd_action_plan/en/.
38. GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 2017, 390(10100): 1345-1422.
39. 周總光, 楊烈, 李園, 等. 我國結直腸癌30年變遷與應對策略. 中國實用外科雜志, 2012, 32(9): 693-696.
40. Ou J, Peng Y, Yang W, et al. ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield. Nat Commun, 2019, 10(1): 1078.
41. Liu X, Wang B, Li Y, et al. Powerful anticolon tumor effect of targeted gene immunotherapy using folate-modified nanoparticle delivery of CCL19 to activate the immune system. ACS Cent Sci, 2019, 5(2): 277-289.
42. He Q, Guo S, Qian Z, et al. Development of individualized anti-metastasis strategies by engineering nanomedicines. Chem Soc Rev, 2015, 44(17): 6258-6286.
43. Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst, 2017, 109(8): djw322.
44. Deng Y. Rectal cancer in Asian vs. Western countries: why the variation in incidence? Curr Treat Options Oncol, 2017, 18(10): 64.
45. Global Burden of Disease Cancer Collaboration. The global burden of cancer 2013. JAMA Oncol, 2015, 1(4): 505-527.
46. Karahalios A, English DR, Simpson JA. Weight change and risk of colorectal cancer: a systematic review and meta-analysis. Am J Epidemiol, 2015, 181(11): 832-845.
47. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015, 385(9963): 117-171.
48. International Agency for Research on Cancer, World Health Organization. CI5plus-cancer incidence in five continents time trends. 2018-04-01. http://ci5.iarc.fr/CI5plus/Default.aspx.

Previous Article
圍產期動脈導管未閉患者并發急性大面積肺栓塞手術治療及圍術期管理一例
Next Article
直腸癌經肛拖出術的臨床應用

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

我國結直腸癌的現狀、制約瓶頸與反思

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content